Globeflex Capital L P Harvard Bioscience Inc Transaction History

Globeflex Capital L P

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.77 - $4.63 $22,957 - $38,373	-8,288 Reduced 5.61%	139,514 $397,000
Q1 2024 May 14, 2024	SELL	$4.02 - $5.39 $39,842 - $53,420	-9,911 Reduced 6.28%	147,802 $626,000
Q3 2023 Nov 13, 2023	SELL	$4.0 - $5.82 $38,428 - $55,912	-9,607 Reduced 5.74%	157,713 $678,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $159,220 - $234,080	38,000 Added 29.38%	167,320 $918,000
Q4 2022 Feb 10, 2023	SELL	$2.12 - $2.86 $200,429 - $270,390	-94,542 Reduced 42.23%	129,320 $358,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.42 $146,301 - $286,357	-44,604 Reduced 16.61%	223,862 $806,000
Q3 2021 Nov 12, 2021	BUY	$6.98 - $8.47 $485,096 - $588,648	69,498 Added 34.93%	268,466 $1.87 Million
Q2 2021 Aug 12, 2021	BUY	$5.44 - $8.4 $184,029 - $284,163	33,829 Added 20.49%	198,968 $1.66 Million
Q1 2021 May 14, 2021	BUY	$3.91 - $6.99 $104,420 - $186,674	26,706 Added 19.29%	165,139 $902,000
Q4 2020 Feb 11, 2021	BUY	$3.0 - $4.5 $53,934 - $80,901	17,978 Added 14.93%	138,433 $594,000
Q3 2020 Nov 13, 2020	SELL	$2.75 - $4.2 $24,406 - $37,275	-8,875 Reduced 6.86%	120,455 $363,000
Q2 2020 Aug 12, 2020	BUY	$2.12 - $3.14 $55,329 - $81,950	26,099 Added 25.28%	129,330 $401,000
Q1 2020 May 13, 2020	BUY	$1.42 - $3.29 $114,030 - $264,196	80,303 Added 350.24%	103,231 $228,000
Q2 2019 Aug 12, 2019	BUY	$1.93 - $4.59 $13,757 - $32,717	7,128 Added 45.11%	22,928 $46,000
Q3 2018 Nov 09, 2018	BUY	$5.0 - $6.65 $79,000 - $105,070	15,800 New	15,800 $83,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.